XFOR Historical PE Ratio image   This XFOR PE ratio history page last updated 11/7/2022
XFOR Historical PE Ratio Chart
PeriodPriceGAAPAnnualizedPE
Q3 2022
11/3/2022
1.89-0.26-1.04NA
Q2 2022
8/4/2022
1.27-0.60-2.40NA
Q1 2022
5/12/2022
1.04-0.72-2.88NA
Q4 2022
3/17/2022
1.77-1.24-4.96NA
Q3 2021
11/4/2021
5.15-0.76-3.04NA
Q2 2021
8/3/2021
5.66-0.74-2.96NA
Q1 2021
5/6/2021
8.12-1.30-5.20NA
Q4 2021
3/4/2021
9.18-0.91-3.64NA
Q3 2020
11/5/2020
6.01-0.87-3.48NA
Q2 2020
7/30/2020
7.73-0.76-3.04NA
Q1 2020
5/7/2020
8.56-0.56-2.24NA
Q4 2020
3/12/2020
8.13-0.66-2.64NA
Q3 2019
11/7/2019
13.41-0.94-3.76NA
Q2 2019
8/7/2019
11.65-1.02-4.08NA
Q1 2019
5/15/2019
20.06-6.67-26.68NA
Q3 2018
11/12/2018
8.04-4.56-18.24NA
Q2 2018
8/13/2018
10.98-5.10-20.40NA
Q1 2018
5/10/2018
120.66-4.44-17.76NA
Q4 2017
3/9/2018
108.00-10.08-40.32NA
XFOR PE History Chart
PeriodPriceGAAPTTMPE
Q3 2022
11/3/2022
1.89-0.26-2.82NA
Q2 2022
8/4/2022
1.27-0.60-3.32NA
Q1 2022
5/12/2022
1.04-0.72-2.72NA
Q4 2022
3/17/2022
1.77-1.24-2.74NA
Q3 2021
11/4/2021
5.15-0.76-2.80NA
Q2 2021
8/3/2021
5.66-0.74-3.82NA
Q1 2021
5/6/2021
8.12-1.30-3.84NA
Q4 2021
3/4/2021
9.18-0.91-3.10NA
Q3 2020
11/5/2020
6.01-0.87-2.85NA
Q2 2020
7/30/2020
7.73-0.76-2.92NA
Q1 2020
5/7/2020
8.56-0.56-3.18NA
Q4 2020
3/12/2020
8.13-0.66-9.29NA
Q3 2019
11/7/2019
13.41-0.94-8.63NA
Q2 2019
8/7/2019
11.65-1.02-12.25NA
Q1 2019
5/15/2019
20.06-6.67-16.33NA
Q3 2018
11/12/2018
8.04-4.56-24.18NA
Q2 2018
8/13/2018
10.98-5.10NANA
Q1 2018
5/10/2018
120.66-4.44NANA
Q4 2017
3/9/2018
108.00-10.08NANA
Quotes delayed 20 minutes

Email EnvelopeFree XFOR Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
X4 Pharmaceuticals (XFOR) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

XGN PE Ratio History
XLRN PE Ratio History
XNCR PE Ratio History
XOMA PE Ratio History
XRAY PE Ratio History
YMAB PE Ratio History
YMTX PE Ratio History
YTEN PE Ratio History
ZBH PE Ratio History
ZGNX PE Ratio History
How should the XFOR historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like X4 Pharmaceuticals. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this XFOR Historical PE Ratio page.

What is the average historical PE for XFOR based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The XFOR historical PE ratio using the annualized quarterly earnings method works out to NA.

What is the average historical PE for XFOR based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The XFOR historical PE ratio using the TTM earnings method works out to NA.

On this page we presented the XFOR Historical PE Ratio information for X4 Pharmaceuticals' stock. The average XFOR historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is NA. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average XFOR historical PE based on this TTM earnings result method is NA. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this XFOR historical PE result, against the recent PE: when this page was posted on 11/4/2022, the most recent closing price for XFOR had been 1.85, and the most recent quarterly earnings result, annualized, was NA. Meanwhile, the most recent TTM earnings summed to NA.

For self directed investors doing their due diligence on XFOR or any other given stock, valuation analysis for XFOR can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate X4 Pharmaceuticals PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for XFOR. Thanks for visiting, and the next time you need to research XFOR Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: CLIX Average Annual Return, R shares outstanding history, GGAL Stock Predictions.

 

XFOR Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.